Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mats Eriksson

Showing results (191-200 of 241) with videos related to

Pageof 25
Sort By:
Journal of Lipid Research|May 13, 2010
HNF1alpha and SREBP2 are important regulators of NPC1L1 in human liverCamilla Pramfalk, Zhao-Yan Jiang, Qu Cai, et al.
Journal of Diabetes and Its Complications|June 21, 2016
LEADER-6: Baseline renal function and associated factors in a high cardiovascular risk type 2 diabetes populationIlhan Satman, Rosangela R Rea, Mats Eriksson, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|March 16, 2016
Biotin and Thiamine Responsive Basal Ganglia Disease--A vital differential diagnosis in infants with severe encephalopathySofia Ygberg, Karin Naess, Mats Eriksson, et al.
Atherosclerosis|May 27, 2009
ACAT2 and human hepatic cholesterol metabolism: identification of important gender-related differences in normolipidemic, non-obese Chinese patientsPaolo Parini, Zhao-Yan Jiang, Curt Einarsson, et al.
Journal of Internal Medicine|April 24, 2014
Reductions in serum levels of LDL cholesterol, apolipoprotein B, triglycerides and lipoprotein(a) in hypercholesterolaemic patients treated with the liver-selective thyroid hormone receptor agonist eprotiromeBo Angelin, Jens D Kristensen, Mats Eriksson, et al.
Clinical Therapeutics|March 15, 2003
A 52-week, multicenter, randomized, parallel-group, double-blind, double-dummy study to assess the efficacy of atorvastatin and simvastatin in reaching low-density lipoprotein cholesterol and triglyceride targets: the treat-to-target (3T) studyAnders G Olsson, Mats Eriksson, Owe Johnson, et al.
Journal of Environmental Radioactivity|August 19, 2023
Restoring areas after a radioactive fallout: A multidisciplinary study on decontaminationChristopher Rääf, Johan Martinsson, Mats Eriksson, et al.
European Journal of Pain (London, England)|September 16, 2021
Dance and yoga reduced functional abdominal pain in young girls: A randomized controlled trialSofie Högström, Anna Philipson, Lars Ekstav, et al.
Cell Metabolism|August 6, 2008
The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in manCecilia Gälman, Tomas Lundåsen, Alexei Kharitonenkov, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|January 17, 2019
Cardiovascular event rates in a high atherosclerotic cardiovascular disease risk population: estimates from Swedish population-based register dataMaria Lindh, Jonas Banefelt, Kathleen M Fox, et al.
Pageof 25

Showing results (191-200 of 241) with videos related to

Sort By:
Pageof 25
Journal of Lipid Research|May 13, 2010
HNF1alpha and SREBP2 are important regulators of NPC1L1 in human liverCamilla Pramfalk, Zhao-Yan Jiang, Qu Cai, et al.
Journal of Diabetes and Its Complications|June 21, 2016
LEADER-6: Baseline renal function and associated factors in a high cardiovascular risk type 2 diabetes populationIlhan Satman, Rosangela R Rea, Mats Eriksson, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|March 16, 2016
Biotin and Thiamine Responsive Basal Ganglia Disease--A vital differential diagnosis in infants with severe encephalopathySofia Ygberg, Karin Naess, Mats Eriksson, et al.
Atherosclerosis|May 27, 2009
ACAT2 and human hepatic cholesterol metabolism: identification of important gender-related differences in normolipidemic, non-obese Chinese patientsPaolo Parini, Zhao-Yan Jiang, Curt Einarsson, et al.
Journal of Internal Medicine|April 24, 2014
Reductions in serum levels of LDL cholesterol, apolipoprotein B, triglycerides and lipoprotein(a) in hypercholesterolaemic patients treated with the liver-selective thyroid hormone receptor agonist eprotiromeBo Angelin, Jens D Kristensen, Mats Eriksson, et al.
Clinical Therapeutics|March 15, 2003
A 52-week, multicenter, randomized, parallel-group, double-blind, double-dummy study to assess the efficacy of atorvastatin and simvastatin in reaching low-density lipoprotein cholesterol and triglyceride targets: the treat-to-target (3T) studyAnders G Olsson, Mats Eriksson, Owe Johnson, et al.
Journal of Environmental Radioactivity|August 19, 2023
Restoring areas after a radioactive fallout: A multidisciplinary study on decontaminationChristopher Rääf, Johan Martinsson, Mats Eriksson, et al.
European Journal of Pain (London, England)|September 16, 2021
Dance and yoga reduced functional abdominal pain in young girls: A randomized controlled trialSofie Högström, Anna Philipson, Lars Ekstav, et al.
Cell Metabolism|August 6, 2008
The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in manCecilia Gälman, Tomas Lundåsen, Alexei Kharitonenkov, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|January 17, 2019
Cardiovascular event rates in a high atherosclerotic cardiovascular disease risk population: estimates from Swedish population-based register dataMaria Lindh, Jonas Banefelt, Kathleen M Fox, et al.
Pageof 25